• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, February 17, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Dr Rene Hessling replaces Joe Redner as Zeiss ANZ managing director

by Myles Hume
November 16, 2021
in Business, Company updates & acquisitions, Local, News
Reading Time: 3 mins read
A A
Departed Zeiss ANZ managing director Joe Redner (left) and his successor Dr Rene Hessling.

Departed Zeiss ANZ managing director Joe Redner (left) and his successor Dr Rene Hessling.

Share on FacebookShare on Twitter

After a career spanning more than 21 years at Zeiss, Mr Joe Redner has departed the company, handing the reins of the Australasia business to Dr Rene Hessling.

Redner retired on 1 October as managing director of Zeiss Australia and New Zealand to pursue personal interests and to spend time as a volunteer on bush fire recovery and ecological projects.

With a background in surgical microscopy, Redner began his Zeiss career in 2000 as an ophthalmic microscope product manager based in Oberkochen, Germany.

He subsequently assumed responsibility for the global microscope business before relocating to Sydney to head up the ANZ medical technology business in 2002. From 2007 to 2015, he served as manager for the ANZ business before relocating to the US to become president of sales and service for Carl Zeiss Meditec, Inc.

In 2017, he was appointed the Asia Pacific head of sales for ophthalmic devices and took on his most recent role as managing director for Australasia in 2018.

“Together with his colleagues, Joe successfully advanced and developed our business wherever he worked. He is an example of how international experience can strengthen networks and collaboration,” Zeiss Group CEO and president Dr Karl Lamprecht said.

“We would like to thank Joe for his exceptional commitment and excellent work, and we wish him all the best for his future endeavours.”

Hessling, who been with the company for almost 20 years, has been based in Sydney since 2015 as division manager for Zeiss Research Microscopy Solutions and Industrial Quality Solutions for ANZ.

With a degree in neurobiology and systematic zoology from the University of Osnabrueck, Germany, he originally joined Zeiss Microscopy in 2002 as an application specialist for confocal microscopy, supporting northern Germany and Scandinavia.

From 2005, he managed the Training Application & Support Centre, a team that provides second-level sales support for the portfolio of microimaging technologies across EMEA.

From 2008 to the end of 2011, Hessling assumed the role of profit centre manager for Zeiss UK before returning to Germany in early 2012 to serve as manager for the German sales organisation, before his 2015 move to Sydney.

“In my previous role, I worked extensively with universities and research organisations in life science and material science across Australia and New Zealand. I’m very excited to now be engaging more broadly with the medical and vision care divisions of Zeiss and our customers within these markets,” Hessling said.

“I feel privileged to work with an extremely passionate team in Zeiss ANZ and to be part of a global organisation with a history of 175 years of providing cutting-edge optical technologies across different markets.”

Hessling said there were numerous new product launches across different business sectors on the horizon.

“The innovation rate at Zeiss has never been higher and our roadmap not only focuses on hardware developments but in particular on digital solutions and data management platforms to connect technologies across complete workflows,” he said.

“We currently have a very experienced team, which we will further expand, and I look forward to working with them to best support these new technologies across Australia and New Zealand.”

More reading

175 years of Zeiss

Gail Giordani appointed to head Zeiss Vision Care ANZ

Eliminating inefficiencies and never-events in cataract surgery

Tags: ANZDr Karl LamprechtJoe Rednermanaging directorRene HesslingZeiss AustralasiaZeiss Group

Related Posts

Smart glasses are seen as the next big advance in wearable technology. Image: EssilorLuxottica.

Sales of AI smart glasses push 18% jump in EssilorLuxottica revenue

by Staff Writer
February 17, 2026

The world’s biggest eyewear maker is riding a surge in demand for AI glasses, reporting a significant rise in fourth-quarter...

Suppliers presenting in ODMA’s Myopia Mastery workshop are also exhibiting in the O-SHOW trade fair. Images: ODMA

Raising the roof at O-SHOW 2026

by Staff Writer
February 16, 2026

Two workshops at O-SHOW 2026 are reframing the future of Australian eyecare – one spotlighting women driving change, the other...

The study confirmed 40 cases of tattoo-associated uveitis. Image: xartproductionstock.adobe.com.

Aussie study highlights growing risk of tattoos to peoples’ vision

by Staff Writer
February 16, 2026

An Australian investigation has highlighted a rare but potentially sight-threatening condition known as tattoo-associated uveitis, after researchers documented dozens of...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited